Furthermore, the increased mtDNA-CN was significantly evident in ALS patients affected by both SOD1 and C9orf72 mutations [51], thus demonstrating the importance of investigating and monitoring the pathophysiological changes connected to ALS mutations through mtDNA-CN content analysis. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.